Page last updated: 2024-12-06

lanthanum chloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

lanthanum chloride: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID64735
MeSH IDM0091719

Synonyms (28)

Synonym
einecs 233-237-5
lanthanum chloride (la2cl6)
ccris 6887
lanthanum(iii) chloride
lanthanum trichloride
lanthanum chloride (lacl3)
lanthanum chloride, anhydrous
lanthanum chloride
lacl3
10099-58-8
lanthanum(iii) chloride, anhydrous, beads, -10 mesh, >=99.99% trace metals basis
lanthanum(iii) chloride, anhydrous, beads, -10 mesh, 99.9% trace metals basis
trichlorolanthanum
ec 233-237-5
unii-04m8624oxv
FT-0689205
lanthanum chloride;lanthanum trichloride;lanthanum(iii) chloride;lanthanum(iii) chloride, anhydrous, ?lacl3
SC10964
lanthanum(iii) chloride, anhydrous, lacl3
DTXSID2051502
FT-0699501
lanthanum(iii) chloride, ultra dry
lanthanum(iii) chloride, anhydrous
mfcd00011068
lanthanum(iii) chloride, anhydrous, beads
AKOS032963570
Q421212
lanthanum(iii) chloride, anhydrous (99.9%-la) (reo)

Research Excerpts

Overview

Lanthanum chloride is a good inhibitor of both the cytosolic and mitochondrial thioredoxin reductase with IC(50) values of 1.75 and 7.46 μM.

ExcerptReferenceRelevance
"Lanthanum chloride (LaCl(3)) is a good inhibitor of both the cytosolic and mitochondrial thioredoxin reductase with IC(50) values of 1.75 and 7.46 μM, respectively. "( Inhibition of thioredoxin reductase by lanthanum chloride.
Bindoli, A; Cesaro, L; Citta, A; Folda, A; Rigobello, MP; Scutari, G, 2012
)
2.09

Effects

ExcerptReferenceRelevance
"Lanthanum chloride (LaCl(3)) has been shown to retard the progression of established atherosclerotic lesions in animal models, and used as a calcium channel blocker in various cellular experiments. "( Lanthanum chloride suppresses hydrogen peroxide-enhanced calcification in rat calcifying vascular cells.
Gou, BD; Shi, Y; Shi, YL; Wang, K; Zhang, TL, 2009
)
3.24

Actions

Lanthanum chloride can inhibit the proliferation and migration of cervical cancer cells. It could also inhibit the expressions of collagen protein, and it may be used to prevent and treat scars.

ExcerptReferenceRelevance
"Lanthanum chloride can inhibit the proliferation and migration of cervical cancer cells, and induce apoptosis by down-regulating cyclinD1, A20, and MMP-9 expressions in vitro."( [Effects of lanthanum chloride on proliferation and migration of human cervical cancer cell line HeLa cells].
Chen, XP; Guo, F; Liu, SS; Lu, D; Miao, LF; Wang, Y; Xiong, QY, 2010
)
2.18
"Lanthanum chloride could inhibit the expressions of collagen protein, and it may be used to prevent and treat scars."( [Effect of lanthanum chloride on expressions of collagen protein in a wound tissue].
Cao, Y; Dai, YC; Li, GH; Li, J; Liu, Q; Wu, XQ; Zhong, XC, 2004
)
2.16

Toxicity

ExcerptReferenceRelevance
"We have established conditions in which soluble Al is toxic to the yeast Saccharomyces cerevisiae."( A1 toxicity in yeast. A role for Mg?
Gardner, RC; MacDiarmid, CW, 1996
)
0.29
" FC combined with Cd(2+) counteracted the toxic effect of Cd(2+) on endogenous growth and significantly decreased Cd(2+) content (not the case for Cd(2+) at the highest concentration) in coleoptile segments."( Fusicoccin counteracts the toxic effect of cadmium on the growth of maize coleoptile segments.
Karcz, W; Kita, A; Kurtyka, R, 2011
)
0.37
" Uranium is known to be toxic to plants and its uptake and toxicity can be influenced by multiple factors such as pH and the presence of different ions."( Calcium affects uranium responses in Arabidopsis thaliana: From distribution to toxicity.
Cuypers, A; Horemans, N; Mertens, A; Nauts, R; Saenen, E, 2022
)
0.72

Bioavailability

ExcerptReferenceRelevance
" A randomized, open-label, parallel-group, phase I study was conducted to determine absolute bioavailability and investigate excretory routes for systemic lanthanum in healthy subjects."( Absolute bioavailability and disposition of lanthanum in healthy human subjects administered lanthanum carbonate.
Damment, SJ; Dennis, K; Pennick, M, 2006
)
0.33

Dosage Studied

40 BALB/c mice were randomly divided into 2 group 2: experimental group injected intraperitoneally with lanthanum chloride of the dosages 10 mg/kg for 3 days and then injected with 1 LD(50) dosage of LPS 30 minutes after the last injection. Control group injected with normal saline for 3 day and then with 1LD(50), 10mg/kg LPS, and 0.5g/kg Lanthanum Chlorine.

ExcerptRelevanceReference
" (2) 40 BALB/c mice were randomly divided into 2 group 2: experimental group injected intraperitoneally with lanthanum chloride of the dosages 10 mg/kg for 3 days and then injected with 1 LD(50) dosage of LPS 30 minutes after the last injection of lanthanum chloride of the dosages 10 mg/kg; and control group injected intraperitoneally with normal saline for 3 days and then with 1 LD(50) dosage of LPS 30 minutes after the last injection of normal saline."( [Anti-endotoxin effect of lanthanum chloride in vivo: an experimental study of mice].
Guo, F; Hu, F; Hu, YY; Wang, Y; Yuan, K, 2004
)
0.84
" Recently, a new medicine, lanthanum carbonate (Fosrenol), has been used to treat chronic renal failure (CRF), and the dosage is much higher than the daily intake of lanthanides."( Neurotoxicological consequence of long-term exposure to lanthanum.
Chai, Z; Feng, L; He, X; Huang, Y; Li, F; Li, Z; Liu, N; Xiao, H; Zhang, Z; Zhao, Y, 2006
)
0.33
" Additional rats were dosed intravenously with lanthanum chloride (0."( Dietary administration in rodent studies distorts the tissue deposition profile of lanthanum carbonate; brain deposition is a contamination artefact?
Cox, AG; Damment, SJ; Secker, R, 2009
)
0.61
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (380)

TimeframeStudies, This Drug (%)All Drugs %
pre-199072 (18.95)18.7374
1990's81 (21.32)18.2507
2000's109 (28.68)29.6817
2010's104 (27.37)24.3611
2020's14 (3.68)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.67 (24.57)
Research Supply Index5.99 (2.92)
Research Growth Index4.58 (4.65)
Search Engine Demand Index63.37 (26.88)
Search Engine Supply Index2.04 (0.95)

This Compound (40.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.51%)5.53%
Reviews3 (0.76%)6.00%
Case Studies1 (0.25%)4.05%
Observational1 (0.25%)0.25%
Other389 (98.23%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]